サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1761142

ジカウイルス検査の世界市場

Zika Virus Testing

出版日
ページ情報
英文 158 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.41円
ジカウイルス検査の世界市場
出版日: 2025年07月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ジカウイルス検査の世界市場は2030年までに3億1,450万米ドルに達する見込み

2024年に2億2,450万米ドルと推定されるジカウイルス検査の世界市場は、分析期間2024-2030年にCAGR 5.8%で成長し、2030年には3億1,450万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである分子検査は、CAGR 6.4%を記録し、分析期間終了時には1億9,240万米ドルに達すると予測されます。血清学的検査分野の成長率は、分析期間中CAGR 4.9%と推定されます。

米国市場は5,870万米ドルと推定、中国はCAGR 9.9％で成長予測

米国のジカウイルス検査市場は2024年に5,870万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 9.9%で推移し、2030年には予測市場規模7,550万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2％と5.9％と予測されています。欧州では、ドイツがCAGR 2.8%で成長すると予測されています。

世界のジカウイルス検査市場- 主要動向と促進要因のまとめ

ジカウイルスの流行の高まりは、効果的な検査ソリューションの必要性をどのように促進しているか？

蚊が媒介する感染症であるジカウイルスの流行は、特に熱帯・亜熱帯地域において、公衆衛生上の重大な課題として浮上しています。小頭症などの重篤な先天性欠損症やその他の神経学的合併症を引き起こす可能性のあるジカウイルス感染症の流行が増加していることから、効果的な検査ソリューションの必要性が浮き彫りになっています。ラテンアメリカ、カリブ海諸国、東南アジア、アフリカの一部の国々では多数の感染例が報告されており、正確で迅速な診断検査に対する緊急の需要が高まっています。世界中のヘルスケア当局や組織は、ウイルスの蔓延を防ぎ、潜在的なアウトブレイクを管理するために、早期診断を重視しています。その結果、ジカウイルス検査は疾病監視プログラムの重要な要素となっており、分子アッセイ、血清学的検査、ポイントオブケア診断など、さまざまな診断検査の需要を押し上げています。

どのような技術革新がジカウイルス検査の能力を高めているか？

技術の進歩はジカウイルス検査の能力を著しく向上させ、より正確、迅速、信頼性の高い診断を可能にしています。リアルタイムポリメラーゼ連鎖反応（RT-PCR）検査のような分子診断の革新は、その高い感度と特異性により、ジカ熱検出の新たな標準となっています。これらの検査は感染から数日以内にウイルスRNAを検出することができ、タイムリーな介入を行うための重要な情報を提供します。さらに、デング熱やチクングニアのような複数のフラビウイルスを同時に検査できるマルチプレックスアッセイの開発が、ヘルスケアプロバイダーの間で人気を集めています。また、迅速診断検査（RDT）や携帯型核酸増幅検査（NAAT）のようなPOCT（Point-of-care testing）ソリューションも、その使いやすさ、手頃な価格、アウトブレイク対策に不可欠な迅速な検査結果を提供できることから、資源が限られた環境で普及しています。

規制当局の承認と資金調達イニシアチブは、ジカウイルス検査市場にどのような影響を与えているか？

ジカウイルス検査市場の形成には、規制当局の承認と資金調達のイニシアチブが重要な役割を果たしています。米国食品医薬品局（FDA）や世界保健機関（WHO）などの政府機関は、ジカウイルスに対する新しい診断検査の承認と検証に積極的に関与しており、必要な感度と特異度の基準を満たしていることを確認しています。さらに、緊急使用許可（EUA）が利用できるようになったことで、大流行時の革新的な診断ツールの市場参入が加速しています。資金面では、政府機関、非政府組織（NGO）、民間団体からの投資の増加が、先進的なジカウイルス検査技術の開発と商業化を大きく後押ししています。このような経済的インセンティブが研究開発活動を促進し、世界の健康問題に対処するためのより強固で拡張可能な検査ソリューションの利用を促進しています。

ジカウイルス検査市場の成長はいくつかの要因によってもたらされる

ジカウイルス検査市場の成長は、ジカ熱感染の増加、分子診断技術やポイントオブケア診断技術の進歩、ヘルスケアインフラや疾病サーベイランスへの投資の増加など、いくつかの要因によって牽引されています。特にジカ熱と他のフラビウイルスが共存する流行地域では、集団発生時の迅速かつ正確な診断の必要性が大きな推進力となっています。マルチプレックスアッセイやポータブルNAATなどの技術的進歩は、検査能力を向上させ、遠隔地や資源が限られた地域への市場参入を拡大しています。さらに、規制当局の承認と政府の資金援助イニシアティブが、ジカウイルス検査の利用可能性とアクセシビリティを高めています。早期診断と予防の重要性に対するヘルスケア提供者や一般市民の意識の高まりも市場成長に寄与しており、ジカウイルス検査は世界の健康安全保障の重要な要素となっています。

セグメント

タイプ（分子検査、血清検査）;エンドユーザー（調査機関、診断研究所、病院・診療所）

調査対象企業の例（注目の11社）

  • Biocan Diagnostics
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Quest Diagnostics, Inc.
  • SD Biosensor, Inc.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15720

Global Zika Virus Testing Market to Reach US$314.5 Million by 2030

The global market for Zika Virus Testing estimated at US$224.5 Million in the year 2024, is expected to reach US$314.5 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of the analysis period. Growth in the Serological Testing segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$58.7 Million While China is Forecast to Grow at 9.9% CAGR

The Zika Virus Testing market in the U.S. is estimated at US$58.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$75.5 Million by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Zika Virus Testing Market - Key Trends & Drivers Summarized

How Is the Rising Prevalence of Zika Virus Driving the Need for Effective Testing Solutions?

The outbreak of the Zika virus, a mosquito-borne disease, has emerged as a significant public health challenge, particularly in tropical and subtropical regions. The increasing prevalence of Zika virus infections, which can lead to severe birth defects such as microcephaly and other neurological complications, has underscored the need for effective testing solutions. Countries in Latin America, the Caribbean, Southeast Asia, and parts of Africa have reported numerous cases, driving urgent demand for accurate and rapid diagnostic tests. Healthcare authorities and organizations worldwide are emphasizing early diagnosis to prevent the spread of the virus and manage potential outbreaks. Consequently, Zika virus testing has become a critical component of disease surveillance programs, boosting the demand for a variety of diagnostic tests, including molecular assays, serological tests, and point-of-care diagnostics.

What Technological Innovations Are Enhancing Zika Virus Testing Capabilities?

Technological advancements are significantly enhancing the capabilities of Zika virus testing, enabling more accurate, rapid, and reliable diagnosis. Innovations in molecular diagnostics, such as real-time polymerase chain reaction (RT-PCR) tests, have set a new standard for Zika detection due to their high sensitivity and specificity. These tests can detect the viral RNA within days of infection, providing crucial information for timely intervention. Additionally, the development of multiplex assays that can simultaneously test for multiple flaviviruses, such as dengue and chikungunya, is gaining traction among healthcare providers. Point-of-care testing (POCT) solutions, such as rapid diagnostic tests (RDTs) and portable nucleic acid amplification tests (NAATs), are also becoming popular in resource-limited settings due to their ease of use, affordability, and ability to deliver quick results, which are essential for outbreak control.

How Are Regulatory Approvals and Funding Initiatives Influencing the Zika Virus Testing Market?

Regulatory approvals and funding initiatives play a crucial role in shaping the Zika virus testing market. Government agencies, such as the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO), have been actively involved in approving and validating new diagnostic tests for Zika virus, ensuring they meet the necessary sensitivity and specificity criteria. Additionally, the availability of emergency use authorizations (EUAs) has accelerated the market entry of innovative diagnostic tools during outbreaks. On the funding side, increased investment from government bodies, non-governmental organizations (NGOs), and private entities has significantly supported the development and commercialization of advanced Zika virus testing technologies. These financial incentives are driving research and development activities, promoting the availability of more robust and scalable testing solutions to address global health concerns.

The Growth in the Zika Virus Testing Market Is Driven by Several Factors

The growth in the Zika virus testing market is driven by several factors, including the increasing prevalence of Zika infections, advancements in molecular and point-of-care diagnostic technologies, and rising investments in healthcare infrastructure and disease surveillance. The need for rapid and accurate diagnosis during outbreaks is a significant driver, particularly in endemic regions where Zika co-circulates with other flaviviruses. Technological advancements, such as multiplex assays and portable NAATs, are enhancing testing capabilities and expanding the market's reach to remote and resource-limited areas. Additionally, regulatory approvals and government funding initiatives are boosting the availability and accessibility of Zika virus tests. The growing awareness among healthcare providers and the general public about the importance of early diagnosis and prevention is also contributing to market growth, making Zika virus testing a vital component of global health security.

SCOPE OF STUDY:

The report analyzes the Zika Virus Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Molecular Testing, Serological Testing); End-Use (Research Institutes, Diagnostic Laboratories, Hospitals & Clinics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 11 Featured) -

  • Biocan Diagnostics
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Quest Diagnostics, Inc.
  • SD Biosensor, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Zika Virus Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising incidence of Zika virus infections drives demand for advanced testing solutions
    • Growing government initiatives and public health programs boost market growth
    • Technological advancements in diagnostic testing kits enhance market opportunities
    • Increasing adoption of point-of-care testing kits to improve accessibility
    • Development of multiplex assays for simultaneous detection fuels market demand
    • Expansion of laboratory infrastructure in emerging markets spurs market growth
    • Growing awareness among populations about Zika virus testing enhances market potential
    • Strategic collaborations between research institutions and diagnostic companies propel innovation
    • Increasing focus on developing rapid and cost-effective diagnostic solutions drives market
    • Growing investments in research and development for novel testing methods support market expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Zika Virus Testing Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Zika Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Molecular Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Molecular Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Molecular Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Serological Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Serological Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Serological Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • JAPAN
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • CHINA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • EUROPE
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Zika Virus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • FRANCE
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • GERMANY
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Zika Virus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • INDIA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Zika Virus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Zika Virus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • AFRICA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030

IV. COMPETITION